Sharon Jackson

FDA approves Alzheimer’s disease treatment under clinical trial at University of Kentucky

BY: - July 7, 2023

A key antibody treatment in the fight against Alzheimer’s disease, which the University of Kentucky has been studying, just got a full green light from the U.S. Food and Drug Administration.  The approval, which came out Thursday afternoon, means that many Kentuckians with mild cognitive impairment may enjoy an extension of their quality of life.  […]